Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$556K Buy
7,623
+817
+12% +$57.7K 0.39% 110
2018
Q3
$461K Hold
6,806
0.24% 125
2018
Q2
$394K Buy
6,806
+4,041
+146% +$228K 0.2% 126
2018
Q1
$144K Hold
2,765
0.14% 111
2017
Q4
$148K Buy
+2,765
New +$153K 0.09% 127

Other funds holding MRK

Kaizen Advisory's MRK Position: Q4 2018 in Review

Kaizen Advisory increased its Merck (MRK) stake by 12% in Q4 2018, buying an estimated $57.7K and bringing the position to 7,623 shares worth $556K. The position accounts for 0.39% of the portfolio, ranked #110.

Kaizen Advisory first reported a position in MRK in Q4 2017 and has held it in 5 quarters since. 2,250 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

  • Kaizen Advisory held 7,623 shares of Merck worth $556K as of Q4 2018.
  • Kaizen Advisory bought 817 Merck shares in Q4 2018, an estimated $57.7K.
  • Merck made up 0.39% of Kaizen Advisory's portfolio in Q4 2018, its #110 holding.
  • Kaizen Advisory first reported a position in Merck in Q4 2017 and has held it in 5 quarters since.
  • 2,250 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.